TapewireFind a company

person · Reporting owner

MOORE NICHOLAS G

Disclosed activity across 2 companies

Tapewire entity
12744
SEC CIK
0001216923

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
GILEAD SCIENCES, INC.GILD · Entity 405DirectorMarch 29, 2018April 02, 2018
WELLS FARGO & COMPANY/MNWFC · Entity 2824DirectorApril 01, 2013April 02, 2013

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GILEAD SCIENCES, INC.

Report date March 29, 2018 · Filed April 02, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct27,375.7941 Reported balance After 2018-03-29 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2018-03-29 · Grant · Acquired 205.4266 · Balance 27,375.7941

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

WELLS FARGO & COMPANY/MN

Report date April 01, 2013 · Filed April 02, 2013

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible securityDirect61,962.9483 Reported balance After 2013-04-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2013-04-01 · Grant · Acquired 1,651.7736 · Balance 61,962.9483

F2: Conversion price is 1-for-1

F3: Deferred compensation shares payable in installments depending upon director's election.

Common Stock, $1 2/3 Par ValueSEC Table I · non-derivativeDirect1,122.938 Reported balance Holding disclosure · report date 2013-04-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,122.938

F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013.

Common Stock, $1 2/3 Par ValueSEC Table I · non-derivativeIndirectThrough Family Trust1,000 Reported balance Holding disclosure · report date 2013-04-01 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,000

Filing footnotes · ownership attribution and instrument terms

F1: Includes 7.866 shares acquired through Wells Fargo & Company's dividend reinvestment plan on 3/1/2013.

F2: Conversion price is 1-for-1

F3: Deferred compensation shares payable in installments depending upon director's election.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 29, 2018 Filed Apr 2, 2018 23:38 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 205.4266 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-013416 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,375.7941

Underlying: Common Stock · 205.4266 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2018 Filed Mar 6, 2018 01:42 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 178 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010264 · form4.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,170

Underlying: Common Stock · 178 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · shares: An aggregate of 178.180639 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.180639 was paid out in cash in connection with the conversion into shares of common stock.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2018 Filed Mar 6, 2018 01:42 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 178 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-010264 · form4.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 23:29 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 194.8116 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-000220 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,348.5481

Underlying: Common Stock · 194.8116 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 28, 2017 Filed Oct 3, 2017 00:12 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 173.3998 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-028708 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,153.7366

Underlying: Common Stock · 173.3998 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 01, 2017 Filed Jul 5, 2017 21:47 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 953 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023025 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,980.3368

Underlying: Common Stock · 953 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 17:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 189.6079 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-022502 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,027.3368

Underlying: Common Stock · 189.6079 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 10, 2017 Filed May 12, 2017 21:59 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,241 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-017998 · form4.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,377

Underlying: Common Stock · 2,241 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 10, 2017 Filed May 12, 2017 21:59 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 10,376 $0.00 Strike: $66.92 $0.00
Disclosure

SEC source: 0001127602-17-017998 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,376

Underlying: Common Stock · 10,376 shares

Expires 2027-05-10

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 30, 2017 Filed Apr 3, 2017 22:18 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 197.4375 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-013645 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,837.7288

Underlying: Common Stock · 197.4375 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 23:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 173 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001127602-17-010300 · form4.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,640

Underlying: Common Stock · 173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · shares: An aggregate of 173.167681 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.167681 was paid out in cash in connection with the conversion into shares of common stock.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 23:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 173 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010300 · form4.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
December 29, 2016 Filed Jan 4, 2017 00:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 167.1119 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-000368 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,813.459

Underlying: Common Stock · 167.1119 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
November 21, 2016 Filed Nov 29, 2016 19:44 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GiftCommon Stock 3,406 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-068568 · form4.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,882

F1 · shares: Shares gifted to a charitable fund

Read SEC document
September 29, 2016 Filed Oct 3, 2016 23:58 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 153.8846 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-063782 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,646.3472

Underlying: Common Stock · 153.8846 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 01, 2016 Filed Jul 6, 2016 21:35 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 795 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-057638 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,492.4625

Underlying: Common Stock · 795 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2016 Filed Jul 1, 2016 17:43 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 140.2926 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-056783 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,697.4625

Underlying: Common Stock · 140.2926 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 11, 2016 Filed May 13, 2016 23:41 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 7,321 $0.00 Strike: $83.90 $0.00
Disclosure

SEC source: 0001127602-16-052226 · form4.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,321

Underlying: Common Stock · 7,321 shares

Expires 2026-05-11

F3 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 11, 2016 Filed May 13, 2016 23:41 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 1,787 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-16-052226 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,136

Underlying: Common Stock · 1,787 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 30, 2016 Filed Apr 1, 2016 19:53 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 114.2812 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-048095 · form4.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,557.1699

Underlying: Common Stock · 114.2812 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2016 Filed Mar 3, 2016 19:41 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 169 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001127602-16-044737 · form4.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,443

Underlying: Common Stock · 169 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F3 · shares: An aggregate of 169.251544 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.251544 was paid out in cash in connection with the conversion into shares of common stock.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2016 Filed Mar 3, 2016 19:41 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 169 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-16-044737 · form4.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
December 30, 2015 Filed Jan 4, 2016 23:46 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 103.1604 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-16-016961 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,612.1403

Underlying: Common Stock · 103.1604 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 29, 2015 Filed Oct 1, 2015 20:39 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 109.2903 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-013512 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,508.98

Underlying: Common Stock · 109.2903 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
July 01, 2015 Filed Jul 6, 2015 20:48 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 581 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-010921 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,399.6897

Underlying: Common Stock · 581 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2015 Filed Jul 1, 2015 22:49 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 88.381 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001179110-15-010625 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,818.6897

Underlying: Common Stock · 88.381 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 06, 2015 Filed May 7, 2015 21:16 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Units · Derivative 1,466 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-15-007269 · edgar.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,349

Underlying: Common Stock · 1,466 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 06, 2015 Filed May 7, 2015 21:16 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-Qualified Stock Options (Right to Buy) · Derivative 5,167 $0.00 Strike: $102.27 $0.00
Disclosure

SEC source: 0001179110-15-007269 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

Underlying: Common Stock · 5,167 shares

Expires 2025-05-06

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 01, 2015 Filed Mar 3, 2015 21:11 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 167 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-15-003910 · edgar.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,728

Underlying: Common Stock · 167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F3 · shares: An aggregate of 167.168 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.168 was paid out in cash in connection with the conversion into shares of common stock.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2015 Filed Mar 3, 2015 21:11 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 167 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-15-003910 · edgar.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
July 28, 2014 Filed Jul 30, 2014 16:17 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 45,000 $0.00 Strike: $26.62 $0.00
Disclosure

SEC source: 0001179110-14-012139 · edgar.xml · derivative · entry 3

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

Underlying: Common Stock · 45,000 shares

Expires 2018-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
July 28, 2014 Filed Jul 30, 2014 16:17 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 45,000 $90.56 $4,075,402.50
Disclosure

SEC source: 0001179110-14-012139 · edgar.xml · nonDerivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

F2 · price: Sale prices reported for the transactions reported here range from $90.525 to $90.605. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
July 28, 2014 Filed Jul 30, 2014 16:17 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 45,000 $26.62 $1,197,675.00
Disclosure

SEC source: 0001179110-14-012139 · edgar.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 45,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2014 Filed Jul 2, 2014 20:24 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Shares · Derivative 791 $0.00 $0.00
Disclosure

SEC source: 0001179110-14-011276 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,895

Underlying: Common Stock · 791 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 07, 2014 Filed May 9, 2014 00:49 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Units · Derivative 1,904 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-14-008017 · edgar.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,883

Underlying: Common Stock · 1,904 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 07, 2014 Filed May 9, 2014 00:49 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-Qualified Stock Options (Right to Buy) · Derivative 4,868 $0.00 Strike: $78.77 $0.00
Disclosure

SEC source: 0001179110-14-008017 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,868

Underlying: Common Stock · 4,868 shares

Expires 2024-05-07

F1 · derivative.exercise_date: Options vest quarterly over the first year of service upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 01, 2014 Filed Mar 4, 2014 23:35 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 167 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-14-004382 · edgar.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,104

Underlying: Common Stock · 167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F3 · shares: An aggregate of 167.168 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.168 was paid out in cash in connection with the conversion into shares of common stock.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
March 01, 2014 Filed Mar 4, 2014 23:35 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 167 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-14-004382 · edgar.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.

Read SEC document
February 26, 2014 Filed Feb 28, 2014 17:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 20,000 $0.00 Strike: $26.62 $0.00
Disclosure

SEC source: 0001179110-14-003908 · edgar.xml · derivative · entry 3

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 45,000

Underlying: Common Stock · 20,000 shares

Expires 2018-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
February 26, 2014 Filed Feb 28, 2014 17:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 20,000 $84.05 $1,681,070.00
Disclosure

SEC source: 0001179110-14-003908 · edgar.xml · nonDerivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

F2 · price: Sale prices reported for the transactions reported here range from $83.86 to $84.40. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
February 26, 2014 Filed Feb 28, 2014 17:50 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 20,000 $26.62 $532,300.00
Disclosure

SEC source: 0001179110-14-003908 · edgar.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 19, 2014 Filed Feb 21, 2014 19:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 19,068 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001179110-14-003304 · edgar.xml · derivative · entry 4

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

Underlying: Common Stock · 19,068 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
February 19, 2014 Filed Feb 21, 2014 19:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 11,892 $82.89 $985,733.83
Disclosure

SEC source: 0001179110-14-003304 · edgar.xml · nonDerivative · entry 3

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

F3 · price: Sale prices reported for the transactions reported here range from $82.35 to $83.34. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
February 19, 2014 Filed Feb 21, 2014 19:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 7,176 $83.51 $599,256.28
Disclosure

SEC source: 0001179110-14-003304 · edgar.xml · nonDerivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 11,892

F2 · price: Sale prices reported for the transactions reported here range from $83.35 to $83.79. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
February 19, 2014 Filed Feb 21, 2014 19:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 19,068 $22.02 $419,782.02
Disclosure

SEC source: 0001179110-14-003304 · edgar.xml · nonDerivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 19,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2014 Filed Feb 18, 2014 23:12 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GiftNon-Qualified Stock Options (right to buy) · Derivative 19,068 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001179110-14-003007 · edgar.xml · derivative · entry 4

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 19,068

Underlying: Common Stock · 19,068 shares

Expires 2019-05-06

F1 · kind: Transferred to a trust where the Reporting Person is the trustor.

F2 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
February 14, 2014 Filed Feb 18, 2014 23:12 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GiftNon-Qualified Stock Options (right to buy) · Derivative 65,000 $0.00 Strike: $26.62 $0.00
Disclosure

SEC source: 0001179110-14-003007 · edgar.xml · derivative · entry 3

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2018-05-08

F1 · kind: Transferred to a trust where the Reporting Person is the trustor.

F2 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
February 14, 2014 Filed Feb 18, 2014 23:12 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GiftNon-Qualified Stock Options (right to buy) · Derivative 19,068 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001179110-14-003007 · edgar.xml · derivative · entry 2

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,068 shares

Expires 2019-05-06

F1 · kind: Transferred to a trust where the Reporting Person is the trustor.

F2 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
February 14, 2014 Filed Feb 18, 2014 23:12 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GiftNon-Qualified Stock Options (right to buy) · Derivative 65,000 $0.00 Strike: $26.62 $0.00
Disclosure

SEC source: 0001179110-14-003007 · edgar.xml · derivative · entry 1

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 65,000 shares

Expires 2018-05-08

F1 · kind: Transferred to a trust where the Reporting Person is the trustor.

F2 · derivative.exercise_date: Options vest quarterly over a period of one year from the date of grant.

Read SEC document
August 30, 2013 Filed Sep 4, 2013 23:09 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative 130,000 $0.00 Strike: $20.71 $0.00
Disclosure

SEC source: 0001179110-13-013834 · edgar.xml · derivative · entry 6

MOORE NICHOLAS G · CIK 0001216923 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 0

Underlying: Common Stock · 130,000 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: Options are 100% vested on the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.